Geneva Partners’s Teradyne TER Stock Holding History
Bought
Maintained
Sold
Other funds holding TER
AHT
Geneva Partners's TER Position: Q3 2026 in Review
Geneva Partners sold out of Teradyne (TER) in Q3 2026, closing a stake of 28,502 shares — an estimated $13.8M sold.
Geneva Partners first reported a position in TER in Q2 2020 and held it in 2 quarters. The position peaked at $13.8M in Q2 2026. 387 funds tracked by Wall St. Rank hold TER as of Q3 2026.
- Geneva Partners reported no remaining Teradyne position as of Q3 2026 after selling out during the quarter.
- Geneva Partners sold 28,502 Teradyne shares in Q3 2026, an estimated $13.8M.
- Geneva Partners first reported a position in Teradyne in Q2 2020 and held it in 2 quarters.
- Geneva Partners's Teradyne position peaked at $13.8M in Q2 2026.
- 387 funds tracked by Wall St. Rank held Teradyne as of Q3 2026.
Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.